Adult ADHD Screening: Using the ASRS in Clinical Practice
Adult ADHD is having a moment. Awareness has surged, referrals have multiplied, and suddenly every clinician's caseload seems to include patients wondering whether they have ADHD. Some of these patients clearly do. Some clearly don't. And many fall into an ambiguous middle ground where structured screening is genuinely helpful.
The Adult ADHD Self-Report Scale (ASRS), available in both the 6-item screening version (ASRS-5/v1.1 Part A) and the full 18-item version, provides a validated framework for this clinical question.
Why Screening Matters
Adult ADHD affects approximately 2.5–4% of the adult population, but it's both overdiagnosed in some contexts and underdiagnosed in others. The challenge for clinicians isn't whether ADHD exists (it clearly does, with solid neurobiological evidence) but whether a specific patient's difficulties reflect ADHD or something else.
This is harder than it sounds. The symptoms of ADHD overlap substantially with depression (poor concentration, low motivation, forgetfulness), anxiety (restlessness, difficulty relaxing, racing thoughts), sleep disorders (daytime inattention, fatigue), and trauma (emotional dysregulation, difficulty with executive function). A structured screener provides an objective data point alongside clinical judgment.
The ASRS-5 (Screening Version)
The ASRS-5 contains 6 items that were statistically selected for maximum discriminating power. Patients rate how often they experience each symptom on a 0–4 scale (never to very often).
The items cover:
- Difficulty wrapping up final details of a project
- Difficulty getting things in order for an organized task
- Difficulty remembering appointments or obligations
- Fidgeting or squirming when sitting for a long time
- Feeling overly active or compelled to do things
- Avoidance or delay in getting started on tasks requiring thought
A score of 14 or above on the ASRS-5 suggests elevated ADHD risk and warrants thorough evaluation.
The ASRS-5 is designed as a screener, not a diagnostic tool. It identifies who needs further assessment, not who has ADHD. This distinction matters in the current clinical environment where patient expectations around ADHD diagnosis are high.
The Full ASRS (v1.1)
The full 18-item ASRS covers all DSM-5 ADHD criteria across inattention (9 items) and hyperactivity-impulsivity (9 items). It provides subscale scores for each domain, which helps characterize the presentation type (predominantly inattentive, predominantly hyperactive-impulsive, or combined).
The inattention subscale captures: difficulty sustaining attention, not listening, poor follow-through, disorganization, avoiding sustained mental effort, losing things, distractibility, and forgetfulness.
The hyperactivity-impulsivity subscale captures: fidgeting, leaving seat, restlessness, difficulty engaging in leisure quietly, being "on the go," talking excessively, blurting out answers, difficulty waiting, and interrupting.
Clinical Interpretation
The screening score is a probability indicator, not a diagnosis. ADHD diagnosis requires documented impairment across multiple settings, symptom onset before age 12, and exclusion of alternative explanations. No self-report screener can determine these on its own.
Subscale patterns inform clinical thinking. A patient scoring high on inattention but low on hyperactivity-impulsivity may have a different presentation than one scoring high on both. The predominantly inattentive subtype is more commonly missed in clinical settings because it's less disruptive and less visible.
Context matters more than cutoffs. A patient scoring 13 (just below the screening threshold) who describes lifelong difficulties with organization, has failed repeatedly in careers that require sustained attention, and has a family history of ADHD warrants the same careful evaluation as a patient scoring 16.
Differential Diagnosis Considerations
When ASRS scores are elevated, consider:
Depression. Concentration difficulties and executive dysfunction are core features of depression. If the patient's attention problems coincide with mood episodes and resolve between them, depression is the more likely explanation.
Anxiety. Generalized anxiety produces difficulty concentrating, restlessness, and inability to sit still, all of which elevate ASRS scores. If these symptoms are driven by worry, anxiety is the primary issue.
Sleep disorders. Chronic sleep deprivation produces a clinical picture nearly indistinguishable from ADHD: poor attention, impaired working memory, emotional reactivity, poor decision-making. Always assess sleep before diagnosing ADHD.
Trauma. Complex PTSD and developmental trauma can produce executive dysfunction, emotional dysregulation, and difficulty with sustained attention that mimics ADHD. Careful trauma screening is essential.
The answer might be "both." ADHD is highly comorbid with depression (40–70%), anxiety disorders (25–50%), and substance use disorders. Elevated ASRS scores don't have to represent either ADHD or another condition. Sometimes both are present.
Using the ASRS in Practice
At intake when ADHD is part of the referral question. Start with the ASRS-5 as a screener. If positive, follow with the full ASRS and a full clinical assessment.
When treatment for depression or anxiety isn't working. Undiagnosed ADHD is a common reason for treatment-resistant depression and anxiety. If standard interventions aren't producing expected results, screening for ADHD is worthwhile.
For monitoring medication response. If an ADHD diagnosis is made and medication is initiated, repeated ASRS administration tracks whether symptoms are actually improving on the medication. Patient impression of medication benefit is often influenced by placebo and expectancy effects. The ASRS provides a more structured assessment.
As a complement to collateral information. Self-report alone is insufficient for ADHD diagnosis. Pair the ASRS with collateral information from partners, family members, or childhood school records where available.